Unbound MEDLINE

Rectal misoprostol vs 15-methyl prostaglandin F2alpha for retained placenta after second-trimester delivery.

Abstract

OBJECTIVE
The purpose of this study was to compare rectal misoprostol (RM) with 15-methyl prostaglandin F2alpha (PGF(2alpha)) for the management of retained placenta after second-trimester deliveries.
STUDY DESIGN
A retrospective study of all second-trimester deliveries between the years 2000 and 2005 was performed. Women were divided into 2 groups, depending on whether they received RM or PGF(2alpha) after the delivery.
RESULTS
Three hundred three second-trimester deliveries were analyzed. The time from the administration of medications to the placental delivery was significantly shorter in women who received PGF(2alpha), compared with the RM group (49.5 vs 89 minutes; P < .01). Women who received PGF(2alpha) had lower rates of retained placenta (4.9% vs 12.4%; P = .02).
CONCLUSION
The use of PGF(2alpha) after second-trimester deliveries results in shorter third stage of labor and lower rates of retained placenta compared with RM.

Links

  • Publisher Full Text
  • Authors

    Sundaram S, Diaz JP, González-Quintero VH, Verma U

    Institution

    Department of Obstetrics and Gynecology, University of Miami, Miller School of Medicine, Miami, FL 33136, USA.

    Source

    American journal of obstetrics and gynecology 200:5 2009 May pg e24-6

    MeSH

    Abortifacient Agents, Nonsteroidal
    Abortion, Therapeutic
    Administration, Rectal
    Adult
    Carboprost
    Female
    Humans
    Misoprostol
    Placenta, Retained
    Pregnancy
    Pregnancy Trimester, Second
    Retrospective Studies
    Treatment Outcome
    Young Adult

    Pub Type(s)

    Comparative Study
    Journal Article

    Language

    eng

    PubMed ID

    19136084